Biology is becoming engineerable

we are investing in a future where bioengineering has industrial scale and speed, and today’s barely conceivable medicines are routine

Ring 1
Ring 2
Ring 3
Ring 4
Ring 1
Ring 2
Ring 3
Ring 4

We partner with innovators

building groundbreaking companies with the following characteristics

Advanced or emerging therapeutic platform

novel biologics, cell therapies, gene therapies, and precision small molecules


Treating or curing life-threatening diseases

cardiovascular, infectious, neurologic, oncologic, rheumatologic, and other serious diseases


High-resolution, high-throughput biology

computational drug discovery, novel screening and imaging tools, and multi-omics that accelerate discovery


Designing for manufacturability

appropriate manufacturing at each stage of development

clinical trials

Reaching Human

long-term partnerships with companies from pre-IND to commercialization

At the base of the creativity of all large familiar forms of life, symbiosis generates novelty. It brings together different life-forms, always for a reason.”

— Lynn Margulis, Symbiotic Planet: A New Look at Evolution